521 related articles for article (PubMed ID: 26025192)
1. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.
Lee BT; Ahmed FA; Hamm LL; Teran FJ; Chen CS; Liu Y; Shah K; Rifai N; Batuman V; Simon EE; He J; Chen J
BMC Nephrol; 2015 May; 16():77. PubMed ID: 26025192
[TBL] [Abstract][Full Text] [Related]
2. Not all inflammatory markers are linked to kidney function: results from a population-based study.
Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
[TBL] [Abstract][Full Text] [Related]
3. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.
Gupta J; Mitra N; Kanetsky PA; Devaney J; Wing MR; Reilly M; Shah VO; Balakrishnan VS; Guzman NJ; Girndt M; Periera BG; Feldman HI; Kusek JW; Joffe MM; Raj DS;
Clin J Am Soc Nephrol; 2012 Dec; 7(12):1938-46. PubMed ID: 23024164
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and Progression of CKD: The CRIC Study.
Amdur RL; Feldman HI; Gupta J; Yang W; Kanetsky P; Shlipak M; Rahman M; Lash JP; Townsend RR; Ojo A; Roy-Chaudhury A; Go AS; Joffe M; He J; Balakrishnan VS; Kimmel PL; Kusek JW; Raj DS;
Clin J Am Soc Nephrol; 2016 Sep; 11(9):1546-1556. PubMed ID: 27340285
[TBL] [Abstract][Full Text] [Related]
5. The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.
Kaminski TW; Pawlak K; Karbowska M; Znorko B; Mor AL; Mysliwiec M; Pawlak D
Int Urol Nephrol; 2019 Mar; 51(3):491-502. PubMed ID: 30617956
[TBL] [Abstract][Full Text] [Related]
6. Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients.
Spoto B; Leonardis D; Parlongo RM; Pizzini P; Pisano A; Cutrupi S; Testa A; Tripepi G; Zoccali C; Mallamaci F
Nutr Metab Cardiovasc Dis; 2012 Nov; 22(11):981-8. PubMed ID: 21906921
[TBL] [Abstract][Full Text] [Related]
7. Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease.
Goicoechea M; Quiroga B; García de Vinuesa S; Verdalles U; Reque J; Panizo N; Arroyo D; Santos A; Macías N; Luño J
Ren Fail; 2012; 34(8):1002-9. PubMed ID: 22746155
[TBL] [Abstract][Full Text] [Related]
8. Effects of atorvastatin on biomarkers of inflammation in chronic kidney disease.
Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Coombes JS
Clin Nephrol; 2014 Feb; 81(2):75-85. PubMed ID: 24321183
[TBL] [Abstract][Full Text] [Related]
9. Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease.
Dounousi E; Koliousi E; Papagianni A; Ioannou K; Zikou X; Katopodis K; Kelesidis A; Tsakiris D; Siamopoulos KC
Am J Nephrol; 2012; 36(6):531-6. PubMed ID: 23258075
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and oxidation: do they improve after kidney transplantation? Relationship with mortality after transplantation.
Cañas L; Iglesias E; Pastor MC; Barallat J; Juega J; Bancu I; Lauzurica R
Int Urol Nephrol; 2017 Mar; 49(3):533-540. PubMed ID: 28013471
[TBL] [Abstract][Full Text] [Related]
11. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
Amdur RL; Feldman HI; Dominic EA; Anderson AH; Beddhu S; Rahman M; Wolf M; Reilly M; Ojo A; Townsend RR; Go AS; He J; Xie D; Thompson S; Budoff M; Kasner S; Kimmel PL; Kusek JW; Raj DS;
Am J Kidney Dis; 2019 Mar; 73(3):344-353. PubMed ID: 30545708
[TBL] [Abstract][Full Text] [Related]
12. The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.
Fox ER; Benjamin EJ; Sarpong DF; Nagarajarao H; Taylor JK; Steffes MW; Salahudeen AK; Flessner MF; Akylbekova EL; Fox CS; Garrison RJ; Taylor HA
BMC Nephrol; 2010 Jan; 11():1. PubMed ID: 20078870
[TBL] [Abstract][Full Text] [Related]
13. Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD.
Schei J; Stefansson VT; Mathisen UD; Eriksen BO; Solbu MD; Jenssen TG; Melsom T
Clin J Am Soc Nephrol; 2016 Feb; 11(2):280-6. PubMed ID: 26668020
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
[TBL] [Abstract][Full Text] [Related]
15. Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease.
Okuyan HM; Dogan S; Terzi MY; Begen MA; Turgut FH
Clin Exp Nephrol; 2021 May; 25(5):522-530. PubMed ID: 33548016
[TBL] [Abstract][Full Text] [Related]
16. The association between C-reactive protein levels and the risk for chronic kidney disease hospitalizations in adults of a remote Indigenous Australian community - A prospective cohort study.
Arnold LW; Hoy WE; Wang Z
Nephrology (Carlton); 2017 Sep; 22(9):699-705. PubMed ID: 27312245
[TBL] [Abstract][Full Text] [Related]
17. Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.
Dai L; Watanabe M; Qureshi AR; Mukai H; Machowska A; Heimbürger O; Barany P; Lindholm B; Stenvinkel P
Eur J Intern Med; 2019 Oct; 68():60-65. PubMed ID: 31402276
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
Chen J; Bundy JD; Hamm LL; Hsu CY; Lash J; Miller ER; Thomas G; Cohen DL; Weir MR; Raj DS; Chen HY; Xie D; Rao P; Wright JT; Rahman M; He J
Hypertension; 2019 Apr; 73(4):785-793. PubMed ID: 30776971
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory Markers and Outcomes in Kidney Transplant Recipients.
Molnar MZ; Nagy K; Remport A; Tapolyai MB; Fülöp T; Kamal F; Kovesdy CP; Mucsi I; Mathe Z
Transplantation; 2017 Sep; 101(9):2152-2164. PubMed ID: 27798514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
